Tendo OneGrip - a robotic assistive medical device for spinal cord injury patients
Reference number | |
Coordinator | ExoTendo AB |
Funding from Vinnova | SEK 3 000 000 |
Project duration | April 2023 - September 2025 |
Status | Ongoing |
Venture | Swelife and Medtech4Health - Collaborative Projects for Improved Health |
Call | Swelife and Medtech4Health - Collaborative projects for better health autumn 2022 |
Purpose and goal
Tendo´s soft exoskeleton Tendo OneGrip is a lightweight and energy-efficient robotic glove designed to help people with spinal cord injuries (SCI) regain hand function and increase their independence and quality of life. Tendo will work with Sigma Lundinova to develop a generic version of the device that can reach international markets. Clinical validation will be conducted in collaboration with Sunnaas Rehabiliteringssjukhus (Norway) to prepare for CE certification and market launch.
Expected effects and result
The project´s ultimate goal is to reach a generic product that can be CE marked and thus reach more people, nationally and internationally. The product, OneGrip, will also be validated in a clinical trial. It is a product designed for people with spinal cord injuries to improve their grip function and increase their independence in everyday life and enable more people to return to work. As a results, more people are included in the social, economic and political life, regardless of function, which leads to potential savings for society (UN global objective 3 and 10).
Planned approach and implementation
The project includes two main areas; 1- Optimizing Tendo´s existing technology to enable a generic product that can be CE marked. The technology must also be verified internally and at so-called test houses. The product will then be validated together with possible users at Sunnaas Rehabilitation Hospital hospital in Norway. The work includes recruitment, patient preparation, study execution and report writing. All work steps in the project must be carried out in accordance with the EU regulation on medical products MDR.